WHO ICTRP trial
Evaluating the efficacy of methotrexate in pain severity reduction and…
IRCT20170716035126N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20170716035126N1 |
|---|---|
| Public title | Evaluating the efficacy of methotrexate in pain severity reduction and improvement of quality of life in patients with moderate to severe knee osteoarthritis |
| Scientific title | Evaluating the efficacy of methotrexate in pain severity reduction and improvement of quality of life in patients with moderate to severe knee osteoarthritis |
| Primary sponsor | Ardabil University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Knee osthoarthritis. |
| Interventions | Intervention 1: Both groups will be administered glucoseamine sulfate 1500 mg daily and then in intervention group, methotrexate with the dose of 7.5 mg (3 pills) weekly will be administered and then increased to 15 mg weekly. Intervention… |
| Registration date | Dec 22, 2017 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: